Cargando…
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
Since 1990, the primary criteria used for assessing response to therapy in high-grade gliomas were those developed by Macdonald and colleagues, which incorporated 2-dimensional area measurements of contrast-enhancing tumor regions, corticosteroid dosing, and clinical assessment to arrive at a design...
Autores principales: | Chinot, Olivier L., Macdonald, David R., Abrey, Lauren E., Zahlmann, Gudrun, Kerloëguen, Yannick, Cloughesy, Timothy F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631110/ https://www.ncbi.nlm.nih.gov/pubmed/23529375 http://dx.doi.org/10.1007/s11910-013-0347-2 |
Ejemplares similares
-
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
por: Swanson, Kenneth D., et al.
Publicado: (2016) -
Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022) -
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022) -
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
por: Omuro, Antonio
Publicado: (2022) -
Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study
por: She, Lei, et al.
Publicado: (2022)